← Back to Awards
NIHNATIONAL CANCER INSTITUTE
Project 4: Neoadjuvant Clinical Trial with Pembrolizumab for Locally Advanaced Squamous Cell Carcinoma (SCC)
- Institution
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA
- Principal investigator
- Hassane M Zarour
- Funding
- $50K
- Duration
- 2021–2026
Moonbase score
Still being scored
Abstract
This is a phase II single-arm neoadjuvant pembrolizumab trial in patients with PD-1 naïve resectable locally advanced SCC.
Research team
- John Munn KirkwoodPI
- Hassane M ZarourPI
LOADING MOONBASE SCORE
Questions for UNIVERSITY OF PITTSBURGH AT PITTSBURGH
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of Pittsburgh at PittsburghNot yet scored
Project 5: Microenvironment manipulation using anti-angiogenics to improve immunotherapy in melanoma
Greg M. Delgoffe · $277K · 2025–2026
- NIH · University of Pittsburgh at PittsburghNot yet scored
Therapy with fecal microbiota transplantation and immune checkpoint blockade for solid tumors
Hassane M Zarour · $632K · 2022–2027
- NIH · University of Pittsburgh at PittsburghNot yet scored
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
Diwakar Davar · $482K · 2021–2026